Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes
- PMID: 12484568
- DOI: 10.1093/jnen/61.12.1056
Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes
Abstract
Brain trauma has been shown to be a risk factor for developing Alzheimer disease (AD), and AD-like plaques containing amyloid-beta (Abeta) peptides have been found in the brain shortly following trauma. Here, we evaluated the effects of brain trauma on the accumulation of Abeta and expression of amyloid precursor protein (APP) genes (APP695 and APP751/ 770) over 1 yr in a non-transgenic rodent model. Anesthetized male Sprague-Dawley rats were subjected to parasagittal fluid percussion brain injury of moderate severity (2.5-2.9 atm) or sham treatment and their brains were evaluated at 2, 4, 7, 14 days, and 1, 2, 6, 12 months following injury. Immunohistochemical analysis detected only weak Abeta staining by 2 wk following injury. However, by 1 month to 1 yr following injury, strong immunoreactivity for Abeta was found in damaged axons throughout the thalamus and white matter. Western blot analysis confirmed the accumulation of Abeta peptides in tissue from injured brains. Although in situ hybridization demonstrated an increased gene expression of APP751/770 surrounding the cortical lesion at 2 to 7 days following injury, this expression returned to baseline levels at all subsequent time points and no increase in the expression of APP695 was detected at any time point. These results demonstrate that long-termAbeta accumulation in damaged axons can be induced in a non-transgenic rodent model of brain trauma. Surprisingly, the extent of this Abeta production appeared to be dependent on the maturity of the injury, but uncoupled from the gene expression of APP. Together, these data suggest a mechanism that may contribute to long-term neurodegeneration following brain trauma.
Similar articles
-
Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma.Am J Pathol. 2004 Aug;165(2):357-71. doi: 10.1016/s0002-9440(10)63303-2. Am J Pathol. 2004. PMID: 15277212 Free PMC article.
-
Altered expression of amyloid precursors proteins after traumatic brain injury in rats: in situ hybridization and immunohistochemical study.J Neurotrauma. 2000 Feb;17(2):123-34. doi: 10.1089/neu.2000.17.123. J Neurotrauma. 2000. PMID: 10709870
-
Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury.J Neurotrauma. 2002 May;19(5):601-14. doi: 10.1089/089771502753754073. J Neurotrauma. 2002. PMID: 12042095
-
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?Nat Rev Neurosci. 2010 May;11(5):361-70. doi: 10.1038/nrn2808. Nat Rev Neurosci. 2010. PMID: 20216546 Free PMC article. Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Traumatic brain injury, microglia, and Beta amyloid.Int J Alzheimers Dis. 2012;2012:608732. doi: 10.1155/2012/608732. Epub 2012 May 14. Int J Alzheimers Dis. 2012. PMID: 22666622 Free PMC article.
-
Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.J Neurotrauma. 2011 Feb;28(2):225-36. doi: 10.1089/neu.2010.1595. J Neurotrauma. 2011. PMID: 21175399 Free PMC article.
-
Increased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury.J Cell Physiol. 2017 Mar;232(3):665-677. doi: 10.1002/jcp.25629. Epub 2016 Oct 19. J Cell Physiol. 2017. PMID: 27699791 Free PMC article.
-
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury.Neurobiol Dis. 2023 May;180:106090. doi: 10.1016/j.nbd.2023.106090. Epub 2023 Mar 17. Neurobiol Dis. 2023. PMID: 36934795 Free PMC article. Review.
-
Targeting Neuroinflammation to Treat Alzheimer's Disease.CNS Drugs. 2017 Dec;31(12):1057-1082. doi: 10.1007/s40263-017-0483-3. CNS Drugs. 2017. PMID: 29260466 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous